Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-24 @ 6:29 PM
NCT ID:
NCT00246168
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with rheumatoid arthritis at least 6 months before the participation in the clinical trial, (defined by having more than 4 of the diagnosis criteria suggested by American College of Rheumatology (ACR
* 1987))
* have been on a stable daily dose of an NSAID or a COX-2 inhibitor for at least 30 days prior to the start of the study
* have arthralgia (arthritis pain in the joints) for at least 2 days before the entering clinical trial, with a pain score on the Visual Analogue Scale (VAS) of 40 mm or greater.
Exclusion Criteria:
* Have had an inadequate response to Tramadol HCl therapy, or have discontinued Tramadol HCl therapy due to adverse events
* have taken Tramadol HCl within 30 days prior to study entry
* have recently taken other medications for pain relief, (other than their daily NSAID or COX-2 inhibitor
* daily use of aspirin at a dose greater than 100 mg per day.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
79 Years
Study:
NCT00246168
Study Brief:
Protocol Section:
NCT00246168